Heron Therapeutics | HRTX - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
ALKERMES USD 511.53M 159.98M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amarin USD 143.56M 12.5M 2026-06
ANI Pharmaceuticals USD 360.21M 49.04M 2026-06
Anika Therapeutics USD 38.41M 2.61M 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
Eisai JPY 245.42B 56.22B 2026-03
Emergent BioSolutions USD 111.7M 23.9M 2023-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Heron Therapeutics USD 20.72M 5.4M 2026-06
Insmed USD 544.76M 37.42M 2026-06
Ligand Pharmaceuticals USD 1.01B 891.62M 2026-06
Merck USD 6.85B 1.52B 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 205.88M 61.57M 2026-06
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
Veracyte USD 299.52M 36.38M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06